이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Curaleaf Holdings 관리

관리 기준 확인 2/4

Curaleaf Holdings' CEO는 Matt Darin, May2022 에 임명되었습니다 의 임기는 2.08 년입니다. 총 연간 보상은 $ 5.18M, 14.5% 로 구성됩니다. 14.5% 급여 및 85.5% 보너스(회사 주식 및 옵션 포함). 는 CA$ 22.92M 가치에 해당하는 회사 주식의 0.58% 직접 소유합니다. 22.92M. 경영진과 이사회의 평균 재임 기간은 각각 3.4 년과 5 년입니다.

주요 정보

Matt Darin

최고 경영자

US$5.2m

총 보상

CEO 급여 비율	14.5%
CEO 임기	2.1yrs
CEO 소유권	0.6%
경영진 평균 재임 기간	3.4yrs
이사회 평균 재임 기간	5yrs

최근 관리 업데이트

Recent updates

Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%

Jun 14

Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%

Jan 19

CEO 보상 분석

Matt Darin 의 보수는 Curaleaf Holdings 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Mar 31 2024	n/a	n/a	-US$237m
Dec 31 2023	US$5m	US$750k	-US$230m
Sep 30 2023	n/a	n/a	-US$343m
Jun 30 2023	n/a	n/a	-US$312m
Mar 31 2023	n/a	n/a	-US$268m
Dec 31 2022	US$5m	US$683k	-US$258m
Sep 30 2022	n/a	n/a	-US$157m
Jun 30 2022	n/a	n/a	-US$202m
Mar 31 2022	n/a	n/a	-US$223m
Dec 31 2021	US$2m	US$350k	-US$206m

보상 대 시장: Matt 의 총 보상 ($USD 5.18M )은 Canadian 시장( $USD 3.35M ).

보상과 수익: 회사가 수익성이 없는 동안 Matt 의 보상이 증가했습니다.

CEO

Matt Darin

2.1yrs

테뉴어

US$5,181,965

보상

Mr. Matthew S. Darin, also known as Matt, serves as President and Director at Curaleaf, Inc. He served as President of Curaleaf Holdings, Inc since January 04, 2022 until May 09, 2022 and serves as Chief E...

리더십 팀

이름	위치	테뉴어	보상	소유권
Boris Jordan	Executive Chairman	5.7yrs	US$12.35m	4.88% $ 212.3m
Matthew Darin	Chief Executive Officer	2.1yrs	US$5.18m	0.58% $ 25.2m
Joseph Lusardi	Executive Vice-Chairman	5.7yrs	US$1.23m	0.72% $ 31.1m
Edward Kremer	Chief Financial Officer	1.8yrs	US$2.76m	0.027% $ 1.2m
Peter Clateman	Chief Legal Officer	4.3yrs	US$1.39m	0.11% $ 4.7m
Camilo Lyon	Chief Investment Officer	1.8yrs	데이터 없음	데이터 없음
Jakob Feinstein	Manager of Investor Relations	no data	데이터 없음	데이터 없음
James Shorris	Chief Compliance Officer	4.3yrs	데이터 없음	데이터 없음
Tracy Brady	Senior Vice President of Corporate Communications	4.5yrs	데이터 없음	데이터 없음
Kate Lynch	Executive Vice President of Marketing	3.4yrs	데이터 없음	데이터 없음
Tyneeha Rivers	Chief People Officer	2.1yrs	데이터 없음	데이터 없음
Jessie Kater	Senior Vice President of Innovation	no data	데이터 없음	데이터 없음

3.4yrs

평균 재임 기간

56yo

평균 연령

경험이 풍부한 관리: CURA 의 관리팀은 경험 ( 3.4 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Boris Jordan	Executive Chairman	5.7yrs	US$12.35m	4.88% $ 212.3m
Joseph Lusardi	Executive Vice-Chairman	5.7yrs	US$1.23m	0.72% $ 31.1m
Mitchell Kahn	Director	3.9yrs	US$250.00k	0.046% $ 2.0m
Peter Derby	Independent Director	5.7yrs	US$350.00k	0.076% $ 3.3m
Karl Johansson	Independent Director	5.7yrs	US$350.00k	0.019% $ 831.5k
Robert Schnoll	Member of the Medical Advisory Board	no data	데이터 없음	데이터 없음
Jaswinder Grover	Independent Director	4.3yrs	US$250.00k	0.75% $ 32.7m
Michelle Bodner	Director	1.5yrs	US$250.00k	0.040% $ 1.7m
Shasheen Shah	Independent Director	1.5yrs	US$250.00k	0.0090% $ 389.8k

5.0yrs

평균 재임 기간

60.5yo

평균 연령

경험이 풍부한 이사회: CURA 의 이사회는 경험(평균 재직 기간 5 년)으로 간주됩니다.

Curaleaf Holdings 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Executive Vice-Chairman recently sold CA$706k worth of stock

Curaleaf Holdings, Inc., Annual General Meeting, Jun 14, 2024

Executive Vice-Chairman recently sold CA$860k worth of stock

Curaleaf Holdings, Inc., Annual General Meeting, Oct 04, 2023

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Some Confidence Is Lacking In Curaleaf Holdings, Inc. (TSE:CURA) As Shares Slide 27%

Executive Vice-Chairman recently sold CA$706k worth of stock

Consensus EPS estimates fall by 17%

Curaleaf Holdings, Inc. (TSX:CURA) completed the acquisition of Northern Green Canada Inc. (NGC).

Curaleaf Holdings, Inc., Annual General Meeting, Jun 14, 2024

Curaleaf Holdings, Inc. to Report Q1, 2024 Results on May 09, 2024

Curaleaf Holdings, Inc. (TSX:CURA) signed a deal to acquire Northern Green Canada Inc. (NGC).

Subdued Growth No Barrier To Curaleaf Holdings, Inc. (TSE:CURA) With Shares Advancing 25%

Curaleaf Expands Zero Proof™ Brand Portfolio with Launch of Stir Fast-Acting THC Beverage Mix

Does Curaleaf Holdings (CSE:CURA) Have A Healthy Balance Sheet?

Consensus EPS estimates fall by 36%

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Curaleaf Holdings, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Executive Vice-Chairman recently sold CA$860k worth of stock

Is Curaleaf Holdings (CSE:CURA) Using Too Much Debt?

Curaleaf Expands Brand Portfolio with Launch of Zero Proof ™ Cannabis-Infused Drinkables

Curaleaf Holdings, Inc., Annual General Meeting, Oct 04, 2023

Curaleaf Holdings, Inc.'s Select™ Brand Expands Product Offerings With Launch of Select Liquid Diamonds

Second quarter 2023 earnings: EPS misses analyst expectations

Curaleaf Holdings, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Curaleaf Holdings, Inc. Unveils Strategic National Rebrand of Select

New minor risk - Shareholder dilution

Curaleaf Holdings (CSE:CURA) Has Debt But No Earnings; Should You Worry?

Consensus EPS estimates fall by 66%

Forecast breakeven date moved forward to 2023

Full year 2022 earnings: Revenues in line with analyst expectations

Less than half of directors are independent

Curaleaf Holdings, Inc. Announces Closure of Operations in California, Colorado and Oregon

Forecast to breakeven in 2025

Less than half of directors are independent

Curaleaf Holdings, Inc. Announces Expansion of BlueKudu Infused Chocolate Flavors Available on Florida Retail Menus

Curaleaf Holdings, Inc. Announces the Launch of Adult-Use Sales At Its Bordentown, New Jersey Location

Curaleaf Holdings Relocates Deerfield, IL Dispensary and Opens Doors to Adult-Use Customers

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) completed the acquisition of Tryke Companies, LLC for approximately $180 million.

Executive Vice-Chairman recently sold CA$160k worth of stock

We Think Curaleaf Holdings (CSE:CURA) Is Taking Some Risk With Its Debt

No longer forecast to breakeven

Consensus EPS estimates fall by 42%

No longer forecast to breakeven

Curaleaf Holdings, Inc., Annual General Meeting, Sep 08, 2022

Curaleaf Holdings, Inc. Announces Management Appointments

Curaleaf Holdings, Inc. Launches Plant Precision, New Product Line Targeting Specific Health and Wellness Categories

Consensus forecasts updated

Curaleaf Holdings, Inc. to Report Q2, 2022 Results on Aug 08, 2022

Curaleaf Expands New Jersey Adult-Use Sales to Edgewater Park Dispensary

Curaleaf Expands New Jersey Adult-Use Sales to Edgewater Park Dispensary

Here's Why Curaleaf Holdings (CSE:CURA) Has A Meaningful Debt Burden

First quarter 2022 earnings: EPS exceeds analyst expectations

Curaleaf Holdings, Inc. Reports Impairment Loss for the Quarter Ended March 21, 2022

Curaleaf Holdings, Inc. Announces Executive Changes

Consensus forecasts updated

Forecast breakeven date pushed back to 2023

Curaleaf Holdings, Inc Expands Product Offerings With Launch of BlueKudu Chocolates in Florida

Curaleaf Holdings, Inc., Annual General Meeting, Jun 23, 2022

Curaleaf Holdings, Inc. Announces its Select Brand Launches Limited-Edition Cliq Elite Live Strain in California

Curaleaf Holdings, Inc. to Report Q1, 2022 Results on May 09, 2022

Interim Chief Financial Officer exercised options to buy CA$851k worth of stock.

Curaleaf Holdings, Inc. Reports Impairment of Intangible Assets for the Fourth Quarter Ended December 31, 2021

Full year 2021 earnings: EPS exceeds analyst expectations

Curaleaf Holdings, Inc. (CNSX:CURA) completed the acquisition of Bloom Dispensaries.

Curaleaf Holdings, Inc. (CNSX:CURA) entered into a definitive agreement to acquire Bloom Dispensaries for approximately $210 million.

Curaleaf Holdings, Inc. (CNSX:CURA) agreed to acquire Natural Remedy Patient Center, LLC for $13 million.

Curaleaf Holdings, Inc. announced that it has received $475 million in funding

Curaleaf Holdings, Inc. Launches Select X Bites

Third quarter 2021 earnings released: US$0.081 loss per share (vs US$0.015 loss in 3Q 2020)

Is Curaleaf Holdings (CSE:CURA) A Risky Investment?

Director recently sold CA$1.4m worth of stock

Curaleaf Holdings, Inc. Announces the Release of Cliq by Select

Second quarter 2021 earnings released